Thomas Dupont-Sentilles is a partner in Goodwin’s Private Equity group and advises European and U.S. clients on a broad range of corporate law matters, including domestic and cross-border M&A, private equity deals and leveraged buyouts, venture capital investments and management incentive schemes.

Mr. Dupont-Sentilles also undertakes corporate and commercial advisory work for a broad range of corporate clients and private equity portfolio companies.

Prior to joining Goodwin in 2016, Mr. Dupont-Sentilles was a senior associate in the corporate and private equity team of King & Wood Mallesons LLP (formerly SJ Berwin) for 10 years. In 2007, he spent some time in SJ Berwin’s London office. He was promoted partner in October 2018.

He is fluent in French and English.

Areas of Practice
Domaines D’Expertise





Mr. Dupont-Sentilles’ recent transactions include advising:

  • Céréa Capital on the sale of its stakes in BCF Life Sciences, a French specialist in the extraction of natural amino acids, to MBO Partenaires.
  • Rossignol Group and its investors (including Altor Equity Partners) on the share capital increase subscribed by IDG.
  • Astorg Partners on the sale of its minority stakes in Linxens, a French manufacturer of flexible etched and printed circuits.
  • Surgivisio, a company engaged in the business of development and sale of x-ray 2D/3D medical imaging devices integrating surgical navigation of instruments, in its 10 million Series B investment round.
  • The shareholders of Orthotaxy, a privately-held medtech company developing software-enabled surgery technologies, on its sale to the American group Johnson & Johnson.
  • Céréa Capital on the acquisition of Organic Alliance, one of France's leading online distributors of organic, fresh and ultrafresh food.
  • Equistone Partners Europe on the acquisition of Bruneau, one of France's leading online distributors of office furniture and supplies.
  • Morningside as lead investor in a Series A investment in Alms Therapeutics, a startup engaged in the treatment of type 2 diabetes.
  • Actility, the industry leader in Low Power Wide Area Networks (LPWAN) for the Internet of Things (IoT), on (1) its $75M Series D fundraising and, (2) the acquisition of Abeeway, the geolocation system specialist.
  • Rossignol Group on the acquisition of Felt GmbH and Felt USA, a leading bicycle manufacturer.
  • UroMems, a developer of an artificial urinary sphincter, as issuer on its Series A financing, led by Wellington Partners.
  • The sellers and the management of Ipackchem, a manufacturer of High Performance Rigid Plastics Containers, on the sale of the group to Sagard.
  • Linxens on the acquisition of Smartrac’s SIT division, the world's leading developer, manufacturer and supplier of RFID products and IoT solutions, with sites in the US, Thailand, China, Singapore, Germany and the Netherlands.
  • Vulcain Ingénierie on the acquisition of the Consultys group, a France-based provider of engineering consulting for the pharmaceutical and biotechnology sectors.
  • Chesterfield Technology Investments Limited in its Series B investment round in Molotov.TV, a French online TV channels operator.


  • Ranked as Leading in Private Equity - Mid-cap LBO and Excellent in Private Equity – Venture capital transaction and in Capital Innovation by Décideurs (Leaders League) 2019

In The News









LL.M., 2007
King's College London
Banking and finance law master degree, 2005
University of Paris II - Panthéon-Assas
Master in Business Law, 2004
University of Paris II - Panthéon-Assas



Avocat à la Cour, Paris, France





Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique